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Purpose of review: Acute kidney injury (AKI) is common after major surgery, and is associated with morbidity,
mortality, increased length of hospital stay, and high health care costs. Although recent guidelines for AKI provide
recommendations for identification of patients at risk, monitoring, diagnosis, and management of AKI, there is lack
of understanding to guide successful implementation of these recommendations into clinical practice.
Sources of information: We held a planning meeting with multidisciplinary stakeholders to identify barriers, facilitators,
and strategies to implement recommendations for prevention, early identification, and management of AKI after major
surgery. Barriers and facilitators to knowledge use for peri-operative AKI prevention and care were discussed.
Findings: Stakeholders identified barriers in knowledge (how to identify high-risk patients, what criteria to use for
diagnosis of AKI), attitudes (self-efficacy in preventive care and management of AKI), and behaviors (common use
of diuretics, non-steroidal anti-inflammatory drugs, withholding of intravenous fluids, and competing time demands
in peri-operative care). Educational, informatics, and organizational interventions were identified by stakeholders as
potentially useful elements for future interventions for peri-operative AKI.
Limitation: Meeting participants were from a single centre.
Implications: The information and recommendations obtained from this stakeholder’s meeting will be useful to
design interventions to improve prevention and early care for AKI after major surgery.Abrégé
Objectif de l’étude: L’insuffisance rénale aiguë (IRA) est fréquente à la suite d’une chirurgie importante et elle est
associée à une morbidité, à une mortalité, à une hospitalisation prolongée et à des coûts élevés liés aux soins de
santé. Bien que les lignes directrices récentes concernant l’IRA fournissent des recommandations pour déterminer
les patients à risque, de même que pour contrôler, diagnostiquer et prendre en charge l’IRA, la compréhension fait
défaut pour mener leur mise en place réussie dans la pratique clinique.
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Sources d’information: Nous avons tenu une réunion de planification avec des acteurs pluridisciplinaires afin de
cibler les obstacles, les appuis et les stratégies de mise en œuvre des recommandations pour la prévention,
l’identification précoce et la prise en charge de l’IRA suite à une chirurgie importante. On a abordé les obstacles et
les appuis à l’utilisation des connaissances dans la prévention périopératoire de l’IRA et les soins qui s’y rattachent.
Résultats: Les acteurs ont déterminé les obstacles à la connaissance (comment identifier les patients à risque élevé,
le choix de critères diagnostiques pour l’IRA), les attitudes (l’auto-efficacité dans les soins préventifs et la prise en
charge de l’IRA), et les comportements (l’usage courant de diurétiques, d’anti-inflammatoires non stéroïdiens, la
non-administration de solutés intraveineux, et les contraintes de temps dans les soins périopératoires). Les acteurs
ont défini les interventions éducatives, informatiques et organisationnelles comme des éléments potentiellement
utiles dans les interventions futures en soins périopératoires pour l’IRA.
Limites de l’étude: Les participants à la réunion provenaient d’un seul et même centre.
Impacts: Les informations et recommandations obtenues au cours de la réunion des acteurs seront utiles pour
l’élaboration des interventions afin d’améliorer la prévention et les soins précoces relatifs à l’IRA suite à une
chirurgie majeure.Why is this report/review important?
Acute kidney injury (AKI) is common, and the incidence
of AKI treated with dialysis after major surgery has been
rising in Canada. Although guidelines have recently been
published for AKI, their successful uptake requires en-
gagement with providers from multiple disciplines.
What are they key messages?
Stakeholders identified several barriers in knowledge,
attitudes, and behaviors related to prevention, early iden-
tification, and management of AKI after major surgery.
Educational, informatics, and organizational interven-
tions were identified as potentially useful strategies for
future implementation and evaluation.
Implications for future research/policy
The information from this report can help tailor the design
of future educational, informatics, and organizational inter-
ventions to implement guidelines for AKI in postoperative
care settings.
Introduction
Acute kidney injury (AKI) has an incidence of 1% fol-
lowing all types of surgery, but occurs much more
frequently after cardiac, vascular, and intra-abdominal
surgeries where the incidence ranges from 10-30% [1].
Like AKI in other settings, peri-operative AKI is associ-
ated with increased morbidity, mortality, length of hos-
pital stay, and healthcare costs; and dialysis may be
required in severe cases [2,3]. The incidence of AKI has
risen 4-fold over the past 20 years in North America
[4,5], including a greater than 3-fold increase in the inci-
dence of AKI treated with acute dialysis after major
surgery in Canada [6].
Risk factors for AKI after major surgery include non-
modifiable factors such as age, comorbidities, and surgerytype, as well as potentially modifiable risk factors such as
intravascular volume depletion, hypoperfusion, pre- and
peri-operative medication use, and exposure to intravascu-
lar contrast agents [2]. Medications commonly used in the
peri-operative period that increase the risk of AKI include
non-steroidal anti-inflammatory drugs (NSAIDs), angio-
tensin converting enzyme (ACE) inhibitors, angiotensin
receptor blockers (ARBs), diuretics, and aminoglycoside
antibiotics [2,7]. Despite an understanding of the modi-
fiable risk factors that predispose to AKI, translation of
this knowledge into improvements in care and outcomes
of AKI has been limited.
Recent guidelines for AKI provide diagnostic criteria
(Table 1), recommendations for identification of high
risk patients, appropriate monitoring, and strategies to
ensure timely recognition of AKI [8,9]. However, imple-
mentation of these recommendations into clinical practice
remains challenging because patients who develop AKI
are generally not under the care of kidney specialists. Suc-
cessful uptake requires engagement with providers from
multiple disciplines including nursing, surgery, internal
medicine and critical care. Deficiencies in knowledge and
clinical practice in prevention, early recognition, and man-
agement of AKI are common [10,11].
A recent review of the Kidney Disease Improving Global
Outcomes (KDIGO) AKI guidelines by the Canadian
Society of Nephrology (CSN) highlighted the need to
develop knowledge translation strategies to increase up-
take of recommendations regarding prevention and man-
agement of AKI in Canada [12]. AKI after major surgery
is a prime candidate condition to target because it is of
clinical concern, standards for identification and manage-
ment of the condition exist, and recent data identify
evidence-to-practice gaps [2,13]. In this article we review
information from a planning meeting with multidis-
ciplinary stakeholders to identify barriers, facilitators, and
Table 1 Kidney Disease Improving Global Outcomes
(KDIGO) definition of AKI
Stage Serum creatinine Urine output




2 2.0–2.9 times baseline <0.5 ml/kg/h for ≥12 hours
3 3.0 times baseline or increase
to ≥353.6 μmol/L or initiation
of renal replacement therapy
<0.3 ml/kg/h for ≥24 hours
or anuria for ≥12 hours
Abbreviation: AKI Acute kidney injury.
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prove prevention, early identification, and management of
AKI after major surgery.
Review
Methods
Overview of stakeholder meeting
A planning meeting with 15 participants was held in
Calgary, Alberta in October 2013. Recognizing that care
of patients with AKI after surgery involves providers
from several stakeholder groups, participants included
physician and nursing practitioners from medicine, sur-
gery, critical care, and nephrology along with repre-
sentatives with cross-disciplinary expertise in health
administration, health services research, pharmacy, and
implementation science/knowledge translation (Table 2).
The key objectives of the meeting were to review the
evidence-to-practice gaps that exist for AKI after major
surgery in Alberta, identify barriers and facilitators to pre-
vention, early recognition, and management of AKI after
major surgery, and to identify potential interventions tai-
lored to address these clinical challenges.Table 2 Demographic and professional characteristics of
the meeting participants













aParticipants may be counted more than once.Meeting activities
The meeting consisted of four components. Following
the introduction of all participating stakeholders and an
overview of the objectives of the meeting, a presentation
was given summarizing the current state of knowledge
about AKI risk factors, diagnostic criteria, management,
and outcomes with an emphasis on recent recommenda-
tions provided by the KDIGO AKI guidelines, National
Institute for Clinical Excellence (NICE) AKI guidance,
and the CSN commentary on AKI guidelines [8,9,12].
Next, to highlight local variation in practice and evi-
dence to care gaps, data on the local incidence of AKI
and processes of care after major surgery from local hos-
pitals (Calgary, Canada) were reviewed. Further, the re-
sults of a pre-meeting survey of 20 local clinicians from
surgery, critical care and nephrology were reviewed,
to examine local opinions about agreement with peri-
operative AKI prevention, monitoring, and management
recommendations from the published guidelines [8,9].
The third component of the meeting was a discussion
about barriers and facilitators to uptake of recommenda-
tions for AKI prevention and management. The final
component involved a facilitated group discussion about
interventions and potential strategies that might close
local evidence-to-practice gaps for AKI prevention and
care. Potential interventions were presented according
to the Effective Practice and Organization of Care
(EPOC) Taxonomy of Interventions [14], developed by
the Cochrane Collaboration, and included formal edu-
cation, linkage and exchange, audit and feedback, in-
formatics, patient-direct/patient-mediated interventions,
organizational, shared decision making, and financial in-
centives [13]. Participants were encouraged to ask ques-
tions and initiate discussions throughout the meeting.
The meeting was recorded and content was qualitatively
summarized by two individuals to identify major themes
and recommendations from the discussion. Ethics ap-
proval was obtained from University of Calgary Conjoint
Health Research Ethics Board. All participants reviewed
the final manuscript and agreed upon the content and
recommendations.
Results
Knowledge of local context
The incidence of AKI (identified based on serum cre-
atinine changes and defined according to the KDIGO
definition [9]) after major surgery between 2005 and
2012 in Calgary Zone hospitals ranged from 8.0% after
thoracic surgery to 33.2% after cardiac surgery (Figure 1).
Urine output was recorded in the electronic medical rec-
ord on each shift for 15-25% of patients on surgical
wards on each of the 7 days following surgery, and 45-
60% of patients had fluid balance recorded each day on
each of the first 7 post-operative days. Medications and
Figure 1 Incidence of AKI, according to surgery type, in Calgary Alberta, between 2005–2012. The incidence is shown for each of the
stages of AKI based on serum creatinine changes according to the KDIGO AKI definition. The incidence of all stages of AKI is shown above the
bars for each type of surgery. Abbreviations: AKI = acute kidney injury.
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set of AKI were also examined, according to the type of
surgery performed (Table 3). Diuretics were prescribed
within 24 hours of AKI onset to between 6 to 38% of pa-
tients, while 20-61% of patients were administered intra-
venous crystalloids within 24 hours of AKI recognition.
Between 3 to 14% of patients with AKI were prescribed
an NSAID, and 3 to 18% of patients were prescribed an
ACE inhibitor or ARB within 24 hours after AKI onset.
The results of the pre-meeting survey of local clini-
cians are also summarized in Table 3. Ninety-five per-
cent of clinicians surveyed indicated that urine outputTable 3 Opinions of care providers about medications use aft
prescribed within 24 hours of AKI, according to type of majo






Diuretics should be avoided in the absence
of volume overload after the onset of AKI
19 (95) Diuretics 1
Patients with AKI should not receive NSAIDs
after the onset of AKI
19 (95) NSAID 6
Patients with AKI should avoid ACEI and/or
ARB drugs after the onset of AKI
12 (60) ACEI or ARB 5
Intravenous crystalloids should be used to
optimize hemodynamic status and restore
effective circulating volume and blood
pressure in patients with AKI after major
surgery
20 (100) IV Crystalloid 5
Abbreviations: AKI acute kidney injury, NSAID non-steroidal anti-inflammatory drug, ACEand fluid balance should be monitored daily after sur-
gery. All physicians agreed that intravenous crystalloids
should be used to restore circulating blood volume in
patients with AKI after major surgery, and 95% agreed
that post-surgical patients should not receive diuretics in
the absence of volume overload after AKI onset. Ninety-
five percent of physicians agreed that patients with AKI
should not receive NSAIDs. There was a mixed response
to whether patients with AKI should avoid ACE inhibi-
tors or ARBs with 60% agreeing that they should not
be prescribed, 15% disagreeing with this statement, and
25% being unsure.er onset of AKI and the proportions of these medications
r surgery in Calgary, Alberta, between 2005-2012
that were Prescribed Medication within one day of AKI onset,
e
bdominal,
, (N = 941)
Cardiac,
%, (N = 1550)
Retroperitoneal,
%, (N = 302)
Thoracic,
%, (N = 87)
Vascular,
%, (N = 403)
5 38 6 16 25
7 8 14 3
18 3 6 18
5 20 22 61 52
I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker.
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recognition, and management
The Clinical Practice Guidelines Framework for Improve-
ment [15] was used to categorize major barriers and facili-
tators to adherence to clinical practice guidelines for AKI
raised in discussion with stakeholders. This framework was
designed to evaluate knowledge, attitudes, and behavior
surrounding barriers and facilitators in knowledge use in
health care. The following sections discuss the major bar-
riers and facilitators that were identified by stakeholders.
Table 4 provides a complete list of the key barriers and fa-
cilitators that were identified during the meeting.
Knowledge
Lack of awareness of risk factors for AKI and criteria for
diagnosis of AKI were perceived as important barriers to
prevention and early identification. Physicians noted un-
certainty about features that could be used to identify
patients who were at high risk of AKI, what criteria de-
fined high risk for AKI, and which of several previously
published definitions should be used to identify patients
with AKI. It was noted that many physicians may not
be aware of AKI based on changes in serum creatinine
when the serum creatinine remained within the refer-
ence range, and so AKI may go unrecognized in the
early stages. One participant summarized the problem:
“Some of these early changes in serum creatinine may
not be apparent if you have a 26 μmol/L or 50% increase
in creatinine without triggering an abnormal test result
flag on the laboratory report”. Therefore, lack of aware-
ness of patients at high risk and those in the earliest
stages of AKI may result in lost opportunities to prevent
or reverse AKI soon after its onset.
Lack of familiarity with AKI care was perceived as an-
other barrier to AKI prevention. Participants suggested
surgical residents who are less familiar caring for patients
with AKI may be more likely to prescribe NSAID for anal-
gesia. One participant stated, “We teach residents…if they
have one potentially nephrotoxic drug they shouldn’t get
another…but we know it happens”. There was also con-
cern expressed that providers may not include appropriate
clinical assessment of volume status before making deci-
sions about administration of intravenous fluids or di-
uretics. It was felt that education to improve competency
of clinical assessment of volume status and identification
of medications with effects on kidney function may be
helpful.
There was also concern that physicians may forget
about the impact of medications on kidney function,
which may be especially relevant to busy surgical resi-
dents or bedside physicians covering during late night
shifts or in the face of competing demands, such as
needing to get to the operating room. As one participant
noted, “it’s two a.m. in the morning, and you get calledabout a patient and you forget. You don’t always remem-
ber to ask all the questions you should”. Therefore,
systems to identify patients at high risk or with AKI,
including decision support systems, were identified as
potentially valuable.
Attitudes
Interpretation of evidence was regarded as a key barrier
to knowledge use in clinical care. Referring to the guide-
lines for AKI identification, one participant stated that,
“these guideline definitions have not yet been adopted in
clinical settings. They have really been used for the pur-
poses of identifying acute kidney injury in epidemiologic
studies”. Participants suggested that the use of different
criteria for identification of AKI contributed to variabil-
ity in care and priorities between the major stakeholder
groups. To facilitate interdisciplinary care, they suggested
that physicians in critical care, surgery, medicine, and
nephrology also needed to establish consensus about how
they identified AKI in clinical settings.
Resources and costs were also identified as potential
health system barriers. One participant worried that even
relatively inexpensive tests like serum creatinine could
substantially increase costs if done repeatedly and un-
necessarily. Targeting repeated kidney function measure-
ments and more intensive nursing assessment of vital
signs, weight, and fluid balance to high risk patients was
felt to be an important resource consideration. There was
also the concern that providing intensive therapies such as
dialysis to patients with AKI who are unlikely to survive
may not be appropriate. One participant expressed their
concern over the costs of treating these patients by saying,
“We owe it to society to be a lot more responsible with
the way we use resources because quite frankly, there are
often times we are rather wasteful”. The inclusion of a dis-
cussion about the risks of AKI and its complications with
patients when obtaining informed consent for surgery was
proposed as a potential solution.
Clinician autonomy and clinical judgment were high-
lighted as important facilitators to knowledge use. One
participant asserted, “Given the complexity of illness in
many patients with AKI, you would not want to take
away the ability to use clinical judgment in decision mak-
ing, but it would be helpful to develop interventions that
will support care providers with appropriate knowledge
to make the most informed management decisions”. An-
other participant agreed suggesting that even strict guid-
ance for AKI should allow for clinical judgment: “there
will be exceptions to the rule and we should accept it.
Fortunately, these are in the minority.” Interventions that
support clinical judgment were felt to be an important fa-
cilitator for AKI care.
Finally, lack of self-efficacy was identified as a key bar-
rier. It was acknowledged that many physicians may not
Table 4 Barriers to implementing recommendations for prevention, recognition, and management of Acute Kidney
Injury (AKI) following major surgery, according to the clinical practice guidelines framework for improvement
Knowledge Attitudes Behaviors
Lack of awareness: Interpretation of evidence: Lack of compatibility with current practices:
● Care providers may not know current definition
of AKI based on small change in serum creatinine.
Providers may not be aware that a patient has
Stage 1 AKI when serum creatinine remains within
reference range
● The common research definitions of AKI
differ from those often used in clinical care;
too many different definitions across
research studies
● It is common to give NSAIDs to patients to
control pain and increase mobilization, although
they may contribute to AKI.
● Providers may not be aware of the mortality
and expense associated with AKI; some may not
be aware that it is preventative and modifiable
● Uncertainty about whether AKI guideline
recommendations apply to post-surgical
care
● Many current patients undergoing surgery
have comorbidities and use anti-hypertensive
medications like ACEI/ARB that may contribute
to AKI
● Providers are not always aware of a patient’s
risk of AKI after surgery, and if made aware may
be more careful to implement monitoring and
preventative measures
● Uncertainty about use of medications
such as ACE/ARB, diuretics, and NSAIDs
and risk of AKI in the perioperative period
● Liver surgery patients are kept “dry” to
decrease blood loss and increase transfusion,
but the lack of fluids may contribute to AKI.
Lack of familiarity: Lack of applicability due to patient
characteristics:
● Colorectal surgery patients are also kept “dry”
because of a perception that the anastomotic
failure rate goes down, but the lack of fluids
may contribute to AKI.
● Providers may prescribe ACE inhibitors or ARB
following surgery, in particularly restarting these
medications when they do not recognize a
patient is at risk of AKI
● Belief that AKI guideline recommendations
are not generalizable to post-surgical care
Surgeons often withhold IV fluids in the
24–48 hours following surgery because the
third space volume will be redistributed and
patients retain fluids post-operatively; this
practice may contribute to AKI
● It is common to prescribe NSAIDs following
surgery to reduce pain; providers prescribing
these medications may not be aware of the
patient’s risk or history of AKI
● Cardiac surgery patients already received
intensive post-operative care in intensive
care units, so it less likely that interventions
targeting AKI prevention and recognition
can improve the quality of care or outcomes
in this setting Complexity:
● Providers receive many calls about fluid balance
and output, but may lack skills in determining
volume status
● Patients undergoing colorectal, hepatic,
and some other open abdominal surgeries
are often intentionally kept “dry” to aid
bowel anastomosis, decrease bleeding,
and to avoid volume overload after fluid
shifts into third spaces
● AKI is not a discrete entity
● Recognition of AKI will be inadequate if one
doesn’t know how to respond
Concern about cost impacts:
● Fluid balance (which affects AKI) is
extremely complex
Forgetting:
● Serum creatinine and physiologically
monitoring will increase costs if done
repeatedly
● Physicians do not want to put a Foley
catheter in every patient that has surgery
because there are side effects from this
practice, even when it may improve
recognition of AKI based on low urine output
● Care providers on surgical services experience
many competing demands and are often
primarily concerned about surgical performance;
providing guidance and recommendations may
facilitate better care ● Treating patients that are unlikely to
improve can be expensive
● Low urine output has been described in
varying ways (eg. with or without
standardization by weight and over varying
periods of time), but there is uncertainty about
the way in which urine output should be
measured and recorded, including which is
most valid and should be acted upon.
● Forgetting may be particularly common when
on-call and during night shifts when tired;
residents may be less likely to remember to ask
the important questions to guide care decisions
when called upon
Lack of agreement in general:
Lack of observability:
● Physicians from other specialties may
express competing priorities (i.e., cardiologists
may not agree with withholding ACEI
inhibitors and ARB because they can improve
cardiac output post-operatively)
● Physicians do not always see direct links
between their practices and prevention/
reversal of AKI.
● While some medication types should
generally be withheld, there is a lot of
room for judgment and exceptions for a
minority of patients
● AKI does not have symptoms like many
other diseases to help with identification
and prompt treatment.
Too “cookbook”/rigid to be applicable: Communication:
● Educational initiatives often lack context
and are too far removed from the realities
of the workplace to be relatable
● There is a lack of mechanisms to facilitate
appropriate consultation and communication
between care providers
Challenge to autonomy: ● Communication often does not occur
promptly and so recommendations are not
put in place in a timely manner.● There needs to be room for clinical
judgment because there are always
exceptions ● Nurses routinely notify physicians about
low urine output but changes in serum
creatinine are rarely communicated
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Table 4 Barriers to implementing recommendations for prevention, recognition, and management of Acute Kidney
Injury (AKI) following major surgery, according to the clinical practice guidelines framework for improvement
(Continued)
Not practical: ● Nurses may not give feedback to physicians
following a therapy or intervention that did
not have desired effect.● Current guidelines for AKI are not practical
because they lack specificity about which
patients are “at risk” Time pressure:
Lack of expectation involving feelings: ● Physicians on call receive may calls and
thorough evaluation or recognition of AKI
risk may not occur prior to ordering
medications
● Some physicians may not perceive AKI
as a true threat, but rather, as “just” AKI;
interventions may need to take into
account these preconceptions ● High volume of patients and busy operating
rooms may lower attention to serum
creatinine levelsLack of self-efficacy:
Lack of Resources:● Some physicians may feel that factors
leading to AKI, particularly in elderly patients
with complications and/or comorbidities, are
not modifiable and therefore, they cannot
prevent AKI
● There is a lot of work done by few people;
so intensive physiological and laboratory
monitoring may not be possible for all patients.
Lack of motivation: ● Physicians must often respond to some
problems over the phone rather than at the
bedside● Physicians may not feel motivated to
treat patients that they feel will not improve
(due to age or comorbidities) Organizational constraints:
● Some physicians may lack motivation to
prevent AKI because they are not aware of
its impact
● In some centers the usual practice may
be to consult internal medicine while in
others it will be to consult nephrology for
AKI, depending on the availability of consult
services in the hospital.
Lack of access to services:
● Some centers may not have electronic
health records for reporting and accessing
lab results and for computerized clinical
decision support for medication prescribing
in the setting of reduced kidney function
● Important information may not be
immediately accessible/available when
decisions are being made (ie. lab results
for the day not yet back, urine output not
charted for high risk patients)
Shared responsibility with patient:
● The risks of developing AKI and its
potential consequences may not always
been properly conveyed or framed for a
patient prior to surgery
Abbreviations: AKI acute kidney injury, NSAID non-steroidal anti-inflammatory drug, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin
receptor blocker.
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ect link between preventative measures and positive out-
comes, and therefore fail to take available precautions.
One participant posited, “I think in acute kidney injury
there is a bit of nihilism around prevention and manage-
ment, because there have been many trials of prophy-
lactic and therapeutic agents that have not proven
effective”. Another participant agreed: “yes, I think that
perception of the condition may be a critical barrier to
overcome in order to facilitate uptake of any intervention
aimed to prevent or modify the course of AKI”.Acknowledging this, participants agreed that focusing on
common, evidence-informed practices for AKI prevention
and management, such as appropriate intravenous fluid
administration and avoidance or appropriate dose adjust-
ment of drugs with adverse effects of kidney function were
identified as priorities to improve safety and quality of
care.
Behaviors
The lack of compatibility of some AKI prevention and
management strategies with common peri-operative
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common practices that address competing priorities of
care included: 1) prescribing NSAIDs to post-operative pa-
tients to control pain and increase mobilization; 2) using
diuretics and inhibitors of the renin-angiotensin system to
manage heart failure in cardiac surgery patients, 3) keep-
ing major liver or colorectal surgery patients “dry” during
or after surgery to decrease blood loss/minimize blood
transfusions and reduce the anastomotic leak rate; and
4) being conservative with intravenous fluids post-
operatively following surgery when anticipating redis-
tribution of third space volume back into the intravascular
space to reduce volume overload following surgery. These
modifiable practices were felt to be important targets for
interventions based on intravenous fluid administration
and medication use to prevent AKI after major surgery.
Busy clinical schedules and time pressure were also
identified as key barriers to improving care for AKI. One
participant noted, “I think clinical demands can get over-
whelming when you receive so many calls. You may be
aware the patient is already on an ACE inhibitor but
they require other medicine for their pain and it is easy
to start an NSAID”. Other participants agreed that large
volumes of high-acuity patients and busy operating
rooms may divert attention from patients with rising
serum creatinine measures or other early signs of AKI.
Lack of time may also contribute to the problem of phy-
sicians not being able to provide repeated bedside assess-
ment to assess responses to management implemented in
response to recognition of AKI. Ensuring that clinical in-
formation is readily available to clinicians was felt to be
an important facilitator in the face of competing time
demands.
Effective communication between nurses and physicians
was identified as a facilitator to AKI prevention and care
initiatives on hospital wards. Participants highlighted the
importance of information being relayed about changing
physiological and laboratory values as well as feedback
loops in communication about patients who did not re-
spond to initial management. This was identified as be-
ing especially important on surgical wards where
physicians round early in the day and may otherwise
not be alerted to changes that occur later in the day.
Similarly, participants emphasized the importance of
communication among physicians, including between
the primary physician and consultants as well as at
times of transfer of care. One participant commented,
“An opinion is of no use if no one rolls up their
sleeves and takes action”. Therefore, there may be op-
portunity for improvement through better communi-
cation of the roles and responsibilities of multiple
care providers from difference disciplines who are in-
volved in the care of patients with or at risk of AKI
after surgery.Knowledge translation interventions for AKI prevention,
early recognition, and management
The major goals of a knowledge translation (KT) strat-
egy for AKI after major surgery identified by meeting
participants were to improve recognition of patients at
high risk of AKI, enhance identification of AKI at its earli-
est stages, encourage use of intravenous fluids and avoid-
ance of medications associated with AKI, and facilitate
involvement of specialists in care when indicated. Partici-
pants then discussed several strategies that could be used
to achieve these goals including formal education, linkage
and exchange, audit and feedback, informatics, patient-
direct/patient-mediated interventions, organizational,
shared decision making, and financial incentives [13].
The majority of the discussion focused on three types of
KT interventions for AKI, which participants felt had the
greatest potential for further development and evaluation
for prevention and early management of AKI after major
surgery; 1) formal educational intervention, 2) informat-
ics intervention, and 3) organizational intervention.
Formal educational intervention
Gaps in knowledge about AKI were discussed, based on
a survey of hospital-based trainees from the UK that re-
ported that 50% of trainees could not define AKI, 30%
could not name two or more risk factors for AKI and
37% could not name one or more indication for renal re-
ferral [11]. All participants identified education as an im-
portant form of intervention. One participant declared,
“I believe education should be the basis for any major
initiative. Without education, you can’t go anywhere”.
On the topic of large group interventions, participants
emphasized the importance of starting education about
AKI in medical school and sustaining key messages
throughout training. Such educational initiatives could
be incorporated within surgery and medicine resident
academic half days and later through continuing medical
education programs. In particular, it was felt that educa-
tional initiatives should emphasize modifiable practices
for AKI prevention and the outcomes associated with
AKI, including mortality and costs.
However, large group educational initiatives were seen
as having limited effectiveness when provided in isola-
tion. One participant stated that educational inter-
ventions were often “too put together” and too often
removed from the realities of clinical practice or omitted
practical knowledge and skills to apply in clinical set-
tings. Another participant agreed, saying that infor-
mation often “just washes right past people”. These
concerns highlight the need for educational interventions
to tailor important messages and knowledge to the spe-
cific audience and their workplace. Small group educa-
tional interventions designed to be work-relevant and
relatable were recommended. One participant suggested
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and when to inform physicians. Residents were a sug-
gested target for interventions because they do much of
the ordering of medications and lab testing in teaching
hospitals. It was emphasized that residents from all disci-
plines in medicine and surgery should receive education
on AKI prevention and management. It was also sug-
gested that information sessions for residents may best
be given by other, more senior residents given that they
may be able to provide a more appropriate context for
the discussion.
Clinical informatics intervention
The role of clinical informatics to identify patients at
high risk of AKI and aid in early identification of AKI
was discussed. Two recent studies of informatics inter-
ventions for AKI were presented. In the first study by
McCoy et al. [16], a prompt was displayed in an elec-
tronic medical record whenever there was a significant
change in serum creatinine over the last 48 hours and
listed nephrotoxic drugs and medications requiring dose
adjustment that a patient was currently prescribed. Phy-
sicians were then provided with recommendations to
eliminate or adjust the dose of these medications. The
study reported that nephrotoxic medications were more
likely to be avoided and doses adjusted for kidney func-
tion following the introduction of the intervention. The
second study by Colpaert et al. [17] examined real-time
electronic alerts in an intensive care unit, prompted by
increases in serum creatinine or decreases in urine out-
put based on the RIFLE criteria. The alert, communi-
cated to physicians via their pagers, was associated with
an increase in administration of intravenous fluids. To-
gether, these studies suggested that informatics interven-
tions had the potential to improve processes of care for
AKI in hospital settings.
Meeting participants agreed that having an automated
alert to identify patients who had developed AKI had
high potential as a useful clinical decision support tool.
Participants also suggested that tools to flag patients at
high risk of AKI before surgery had potential value to
make the surgical team aware of this risk and allow pro-
viders to tailor the care of these patients. It was sug-
gested that such tools could be based on the type of
surgery planned, a prior history of kidney disease or
prior episode of AKI, or risk scores for post-operative
AKI. Computerized clinical decision support for medica-
tion prescribing in the setting of AKI was also identified
as a potentially helpful intervention. Although all partici-
pants generally expressed interest in the use of such in-
formatics interventions, some participants also cautioned
that overuse of electronic pop-ups and alerts in electronic
medical records could limit their sustained effectiveness.
Most participants agreed that the implementation of suchinformatics interventions for AKI within clinical workflow
was a worthy initiative for further evaluation as prior stud-
ies suggested that such strategies may improve identifica-
tion, appropriateness, and timeliness of interventions for
AKI [18].
Organizational intervention
Organization interventions incorporating care pathways for
early specialist consultation for AKI were also discussed.
An observational pilot study by Balasubramanian et al. [19]
examined the effectiveness of an organizational interven-
tion where patients with early signs of hospital-acquired
AKI received early nephrologist care. The study reported
that early specialist consultation often resulted in
withdrawal or dose adjustment of medications such as
ACE inhibitors/ARBs and diuretics, and administration
of intravenous fluids. The study reported that early
nephrologist consultation was associated with a lower
incidence of progression to more severe stages of AKI
when compared to a historical control group.
Organizational interventions that included specialist
consultation by internal medicine or nephrology were
thought to be helpful by most participants. “I could see
how a consultant coming when something is triggered
would be extremely helpful”, one participant acknowl-
edged. Participants warned that it would be important to
establish a clear process for automated consultation and
that the admitting surgical team should agree on criteria
for consultation and be notified whenever consultations
were to be made. Some participants emphasized that
consultations performed at the bedside would be prefer-
able to phone-based advice, since they would benefit




At the conclusion of the meeting, three major recom-
mendations were agreed upon by participants. First, par-
ticipants agreed that patients who had undergone major
surgery and were cared for on hospital wards were an
appropriate population to target. Specifically, patients
undergoing major abdominal and vascular surgery were
identified as priority groups because these surgeries
carry high risks of AKI, patients who undergo these pro-
cedures are not routinely cared for in intensive care
units after surgery, and current postoperative care may
be more heterogeneous across hospital wards for these
patients. Second, participants agreed that KT initiatives
for AKI should consider educational interventions, in-
formatics or clinical decision support interventions, and
organizational interventions incorporating consultative
care for AKI. Finally, the following specific elements
were proposed for future implementation and evaluation;
James et al. Canadian Journal of Kidney Health and Disease 2014, 1:20 Page 10 of 10
http://www.cjkhd.org/content/1/1/201) identification of patients undergoing elective, urgent, or
emergency non-cardiac surgical procedures that carry a
high risk of AKI within pre-operative medicine clinics and
upon admission to surgical wards, 2) protocols for stan-
dardized monitoring of daily serum creatinine, shift urine
output, daily fluid balance, and vital sign measurement in
high risk patients; 3) automated systems of immediate at-
tending physician alerting upon recognition of the onset
of AKI that could be implemented through informatics
systems, 4) use of clinical decision support tools for
use of IV crystalloids and avoidance of medications
commonly used after surgery that worsen kidney function
(eg diuretics, NSAIDs, or aminoglycosides), 5) an orga-
nizational system to support appropriate timing and indi-
cations for consultation with critical care, and nephrology,
and 6) an educational program for care providers accom-
panying the implementation of these KT interventions.
In summary, our stakeholder meeting identified sev-
eral barriers and potential facilitators to improve uptake
of clinical practice guidelines for recognition and man-
agement of AKI. Important elements for future KT ini-
tiatives were recommended, incorporating education,
informatics/clinical decision support, and organizational
interventions. Future work will involve designing a KT
intervention based on these principles, implementing
the intervention, and evaluating its effects on the inci-
dence, processes of care, and outcomes of AKI after
major surgery.
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